Business of the House

Of course I understand the hon. Lady’s concern. Health questions will take place next Tuesday, and she has not missed the deadline, so I suggest that she table a question. There is, I think, cross-party agreement that the NICE arrangement for independent assessment of new drug treatments is sensible, and better than the alternative. Whoever is in government, there are critical and difficult questions about whether to approve drugs and make them generally available. That is the reality, but I am aware that some individuals at the margin are disadvantaged and are in a difficult position.